Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Scheinberg

Showing results (101-110 of 121) with videos related to

Pageof 13
Sort By:
Blood|October 1, 1988
Elimination of myeloma cells from bone marrow by using monoclonal antibodies and magnetic immunobeadsC Shimazaki, D Wisniewski, D A Scheinberg, et al.
Leukemia|February 8, 2008
A pilot vaccination trial of synthetic analog peptides derived from the BCR-ABL breakpoints in CML patients with minimal diseaseP G Maslak, T Dao, M Gomez, et al.
The New England Journal of Medicine|January 28, 1988
Infection with human T-cell leukemia virus type I in patients with leukemiaG Y Minamoto, J W Gold, D A Scheinberg, et al.
Blood|April 1, 1988
Human immunodeficiency virus infection in patients with leukemiaG Y Minamoto, D A Scheinberg, K Dietz, et al.
Blood|August 26, 1998
Arsenic trioxide and melarsoprol induce programmed cell death in myeloid leukemia cell lines and function in a PML and PML-RARalpha independent mannerZ G Wang, R Rivi, L Delva, et al.
Cancer|February 1, 1994
Murine and humanized constructs of monoclonal antibody M195 (anti-CD33) for the therapy of acute myelogenous leukemiaP C Caron, M A Schwartz, M S Co, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1990
A phase I toxicity, pharmacology, and dosimetry trial of monoclonal antibody OKB7 in patients with non-Hodgkin's lymphoma: effects of tumor burden and antigen expressionD A Scheinberg, D J Straus, S D Yeh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1991
A phase I trial of monoclonal antibody M195 in acute myelogenous leukemia: specific bone marrow targeting and internalization of radionuclideD A Scheinberg, D Lovett, C R Divgi, et al.
The New England Journal of Medicine|May 26, 1991
Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid)R P Warrell, S R Frankel, W H Miller, et al.
Leukemia|February 1, 1995
Sequential targeted therapy for relapsed acute promyelocytic leukemia with all-trans retinoic acid and anti-CD33 monoclonal antibody M195J G Jurcic, P C Caron, W H Miller, et al.
Pageof 13

Showing results (101-110 of 121) with videos related to

Sort By:
Pageof 13
Blood|October 1, 1988
Elimination of myeloma cells from bone marrow by using monoclonal antibodies and magnetic immunobeadsC Shimazaki, D Wisniewski, D A Scheinberg, et al.
Leukemia|February 8, 2008
A pilot vaccination trial of synthetic analog peptides derived from the BCR-ABL breakpoints in CML patients with minimal diseaseP G Maslak, T Dao, M Gomez, et al.
The New England Journal of Medicine|January 28, 1988
Infection with human T-cell leukemia virus type I in patients with leukemiaG Y Minamoto, J W Gold, D A Scheinberg, et al.
Blood|April 1, 1988
Human immunodeficiency virus infection in patients with leukemiaG Y Minamoto, D A Scheinberg, K Dietz, et al.
Blood|August 26, 1998
Arsenic trioxide and melarsoprol induce programmed cell death in myeloid leukemia cell lines and function in a PML and PML-RARalpha independent mannerZ G Wang, R Rivi, L Delva, et al.
Cancer|February 1, 1994
Murine and humanized constructs of monoclonal antibody M195 (anti-CD33) for the therapy of acute myelogenous leukemiaP C Caron, M A Schwartz, M S Co, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1990
A phase I toxicity, pharmacology, and dosimetry trial of monoclonal antibody OKB7 in patients with non-Hodgkin's lymphoma: effects of tumor burden and antigen expressionD A Scheinberg, D J Straus, S D Yeh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1991
A phase I trial of monoclonal antibody M195 in acute myelogenous leukemia: specific bone marrow targeting and internalization of radionuclideD A Scheinberg, D Lovett, C R Divgi, et al.
The New England Journal of Medicine|May 26, 1991
Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid)R P Warrell, S R Frankel, W H Miller, et al.
Leukemia|February 1, 1995
Sequential targeted therapy for relapsed acute promyelocytic leukemia with all-trans retinoic acid and anti-CD33 monoclonal antibody M195J G Jurcic, P C Caron, W H Miller, et al.
Pageof 13